Medtronic is expanding a recall of two of its MiniMed 600 series insulin pumps after reports found several had broken retainer rings cracked, resulting in insulin doses that were too high or too low.

Medtronic recall: Certain MiniMed insulin pumps have been recalled after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration ...

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...

Medtronic is recalling more than 322,000 of its insulin pumps because of a missing or broken component that can lead to over- or under-delivery of insulin.

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.

The Medtronic pumps affected by the alert are: the MiniMed 508; MiniMed Paradigm models 511, 512/712, 712E, 515/715, 522/722, 522K/722K; plus Paradigm 523/723 and 523K/723K pumps with software ...

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Medtronic has recalled certain MiniMed 600 Series insulin pumps for delivering incorrect insulin dosing due to a missing or broken retainer ring, which helps lock the insulin cartridge in place in ...

(CNN) — Medtronic has recalled some of its insulin pumps after injuries and one death were reported due to the device malfunctioning, according to a US Food and Drug Administration announcement ...